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Mood and anxiety disorders, particularly depression, com-
monly co-occur with human immunodeficiency virus (HIV)
infection1. Although several large studies have established
the prevalence of mood disorders among HIV-positive and
HIV-negative men and women, there is a paucity of informa-
tion about the impact of hospital-associated anxiety and
depression (HAD) on the CD4 counts of naı¨ve HIV/AIDS
patients, even now in the highly active anti-retroviral ther-
apy (HAART) era2. For these reasons, we evaluated the
relationship between HAD and CD4 counts in a cohort of
patients from Peru, recently hospitalized as a result of
HIV/AIDS at two institutions in this south American country,
to investigate if, independently, HAD has a significant impact
on the CD4 counts of these patients.
We adapted,modified and then validated the Zigmond and
Snaith HAD scale (validity coefficient 0.7; Cronbach coeffi-
cient 0.8)3 for detecting states of depression and anxiety in
patients hospitalized as a result of HIV/AIDS in Hospital I
Santa Rosa de Piura and the Hospital de Apoyo III Sullana,
both in Northern Peru. The group comprised adult naı¨ve
patients who were well-informed about the disease and
who required hospitalization as a result of clinical conditions
and/or disease risk, according to laboratory results. Pregnant
women and patients who received psychotropic drugs were
not excluded from the study. At admittance, different clin-
ical and laboratory variables were evaluated, including a
general physical examination, CBC, blood chemistry, CD4
counts (viral load was not measured because of the econom-
ical limitations of this study). HIV infection was diagnosed
with ELISA-HIV-1 and -HIV-2, and confirmed by Western Blot.
The aim of this report is to describe the impact of quantita-
tively assessed anxiety and depression on the CD4 counts,
measured at admittance by flow cytometry. For both scales
(anxiety and depression), values above 11 were indicative of
clinical anxiety and clinical depression. Linear regressions
between anxiety and depression and CD4 counts were calcu-
lated with SPSS 10.0 and GraphPad 4.0, with 95% confidence
( p value significant at <0.05).§ This article formed part of an MD thesis (DZ-C) at the Faculty of
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doi:10.1016/j.ijid.2008.06.013From a total population of 250 patients (60.0% from Piura,
40.0% from Sullana), 77.6% (61.9% Piura, 38.1% Sullana) were
evaluated (IC 95% 71.82—82.5%). After this initial selection,
no patients refused to participate in the study. The mean age
was 35.5 years old (SD  9.9, range 17—68; no significant
differences were observed between the Piura and Sullana
groups, p > 0.05). Male patients formed about 66.7% of the
group. With regard to the non-psychiatric clinical status, no
significant differences were found between illness differ-
ences ( p > 0.05). Using the scale for anxiety, 12.5% were
found to have this condition (mean 7.2  3.8 points, range 0—
17), whereas 18.3% presented with depression (mean
5.2  4.0 points, range 0—15) (no significant differences
were observed between the two locations). Mean CD4 counts
were 262.3 cells/mm3 (167.2, range 11—807), with 36.7%
presenting with <200 cells/mm3. From the linear regres-
sions, a significant relationship was found between CD4
counts and levels of anxiety (r2 = 0.05597, F = 6.996,
p = 0.0093) and depression (r2 = 0.1177, F = 15.75,
p = 0.0001); with higher levels of anxiety and depression,
lower CD4 counts were found (Figure 1).
HIV infection is associated with significant psychological
stresses that require attention in their own right and can
impact medical treatment4. Although it is perhaps to be
expected that people who have HIV and are ill are more
likely to be anxious and depressed, the measurement of
this relationship has not been thoroughly assessed. In this
study, anxiety and depression were found in 12.5% and
18.3% of patients, respectively, and were particularly
related to patients in CDC stage 3 (<200 CD4 cells/mm3)
(Figure 1). The syndromes of depression, anxiety, stress
and substance abuse could be associated with HIV infec-
tion, particularly with the cellular immune status of the
individual. We have shown this herein in a quantitative
way. The CD4 counts have an inverse relationship with
HAD, higher levels of HAD being associated with lower
CD4 lymphocyte counts (Figure 1), independently of other
factors that could influence the impairment of cellular
immunity in these individuals. Although neurobiological
mechanisms remain unknown, a considerable body of basic
and clinical research has documented a relationship
between depression and cell-mediated immunity5. A pre-
vious study has demonstrated that depression and anxiety
are associated with alterations in different measures of
immunity in HIV-seropositive patients5. In further compre-
hensive studies, this relationship could be explored as aPublished by Elsevier Ltd. All rights reserved.
Figure 1 Linear regressions between (A) anxiety and (B) depression and the CD4 counts of naı¨ve HIV/AIDS patients from Peru.
e76 Letter to the Editorpredictor of the cellular immunity of naı¨ve HIV/AIDS
patients, particularly those with <200 CD4 cells/mm3.
For these reasons, the psychosocial context of treatment
is an important factor in HIV care, particularly for special
populations and given its impact on cellular immunity.
Counseling and support groups are important tools in
comprehensive HIV care and should be tailored to the
specific needs of HIV/AIDS patients1,4.
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